Traumatic Brain Injury - Pipeline Review, H1 2019

Publisher Name :
Date: 23-Apr-2019
No. of pages: 336
Inquire Before Buying

Traumatic Brain Injury - Pipeline Review, H1 2019

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2019, provides an overview of the Traumatic Brain Injury (Central Nervous System) pipeline landscape.

Traumatic brain injury happens when an external mechanical force causes brain damage. Traumatic brain injury usually results from a violent blow or jolt to the head or body. Symptoms include headache, dizziness, nausea or vomiting, mood changes, fatigue or drowsiness, difficulty sleeping and memory or concentration problems. Risk factor includes age. Certain types of traumatic brain injury increase the risk of developing Alzheimer's disease and coordination problems.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2019, provides comprehensive information on the therapeutics under development for Traumatic Brain Injury (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Traumatic Brain Injury (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Traumatic Brain Injury and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 7, 8, 77 and 11 respectively. Similarly, the Universities portfolio in Preclinical and Discovery stages comprises 8 and 2 molecules, respectively.

Traumatic Brain Injury (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Traumatic Brain Injury (Central Nervous System).

- The pipeline guide reviews pipeline therapeutics for Traumatic Brain Injury (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Traumatic Brain Injury (Central Nervous System) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Traumatic Brain Injury (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Traumatic Brain Injury (Central Nervous System)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Traumatic Brain Injury (Central Nervous System).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Traumatic Brain Injury (Central Nervous System) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Traumatic Brain Injury - Pipeline Review, H1 2019

Table of Contents
Introduction
Traumatic Brain Injury - Overview
Traumatic Brain Injury - Therapeutics Development
Traumatic Brain Injury - Therapeutics Assessment
Traumatic Brain Injury - Companies Involved in Therapeutics Development
Traumatic Brain Injury - Drug Profiles
Traumatic Brain Injury - Dormant Projects
Traumatic Brain Injury - Discontinued Products
Traumatic Brain Injury - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Traumatic Brain Injury, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Companies, H1 2019 (Contd..1), H1 2019
Number of Products under Development by Companies, H1 2019 (Contd..2), H1 2019
Number of Products under Development by Companies, H1 2019 (Contd..3), H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Products under Development by Companies, H1 2019
Products under Development by Companies, H1 2019 (Contd..1), H1 2019
Products under Development by Companies, H1 2019 (Contd..2), H1 2019
Products under Development by Companies, H1 2019 (Contd..3), H1 2019
Products under Development by Companies, H1 2019 (Contd..4), H1 2019
Products under Development by Universities/Institutes, H1 2019
Number of Products by Stage and Target, H1 2019
Number of Products by Stage and Target, H1 2019 (Contd..1), H1 2019
Number of Products by Stage and Target, H1 2019 (Contd..2), H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019 (Contd..1), H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019 (Contd..2), H1 2019
Number of Products by Stage and Mechanism of Action, H1 2019 (Contd..3), H1 2019
Number of Products by Stage and Route of Administration, H1 2019
Number of Products by Stage and Molecule Type, H1 2019
Traumatic Brain Injury - Pipeline by Alexion Pharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by ALSP Inc, H1 2019
Traumatic Brain Injury - Pipeline by AlzeCure Pharma AB, H1 2019
Traumatic Brain Injury - Pipeline by AMAG Pharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by Amarantus Bioscience Holdings Inc, H1 2019
Traumatic Brain Injury - Pipeline by Anagin Inc, H1 2019
Traumatic Brain Injury - Pipeline by Aptinyx Inc, H1 2019
Traumatic Brain Injury - Pipeline by Athersys Inc, H1 2019
Traumatic Brain Injury - Pipeline by Avanir Pharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by Biogen Inc, H1 2019
Traumatic Brain Injury - Pipeline by CalciMedica Inc, H1 2019
Traumatic Brain Injury - Pipeline by Cantex Pharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by CereSpir Inc, H1 2019
Traumatic Brain Injury - Pipeline by Cognosci Inc, H1 2019
Traumatic Brain Injury - Pipeline by Complement Pharma BV, H1 2019
Traumatic Brain Injury - Pipeline by Eisai Co Ltd, H1 2019
Traumatic Brain Injury - Pipeline by Epigen Biosciences Inc, H1 2019
Traumatic Brain Injury - Pipeline by Hemarina SA, H1 2019
Traumatic Brain Injury - Pipeline by Hoverink Biotechnologies Inc, H1 2019
Traumatic Brain Injury - Pipeline by International Stem Cell Corp, H1 2019
Traumatic Brain Injury - Pipeline by Ischemix Inc, H1 2019
Traumatic Brain Injury - Pipeline by JT Pharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by Levolta Pharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by Mapreg SAS, H1 2019
Traumatic Brain Injury - Pipeline by Neuralstem Inc, H1 2019
Traumatic Brain Injury - Pipeline by Neuren Pharmaceuticals Ltd, H1 2019
Traumatic Brain Injury - Pipeline by NeuroNascent Inc, H1 2019
Traumatic Brain Injury - Pipeline by NeuroVive Pharmaceutical AB, H1 2019
Traumatic Brain Injury - Pipeline by New World Laboratories Inc, H1 2019
Traumatic Brain Injury - Pipeline by NoNO Inc, H1 2019
Traumatic Brain Injury - Pipeline by NuvOx Pharma LLC, H1 2019
Traumatic Brain Injury - Pipeline by Nyrada Inc, H1 2019
Traumatic Brain Injury - Pipeline by Oxeia Biopharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by Peptron Inc, H1 2019
Traumatic Brain Injury - Pipeline by Prevacus Inc, H1 2019
Traumatic Brain Injury - Pipeline by ProThera Biologics Inc, H1 2019
Traumatic Brain Injury - Pipeline by QR Pharma Inc, H1 2019
Traumatic Brain Injury - Pipeline by Qrons Inc, H1 2019
Traumatic Brain Injury - Pipeline by Radikal Therapeutics Inc, H1 2019
Traumatic Brain Injury - Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by Resolys Bio Inc, H1 2019
Traumatic Brain Injury - Pipeline by Rubicon Biotechnology Inc, H1 2019
Traumatic Brain Injury - Pipeline by Sage Therapeutics Inc, H1 2019
Traumatic Brain Injury - Pipeline by Silver Creek Pharmaceuticals Inc, H1 2019
Traumatic Brain Injury - Pipeline by STATegics Inc, H1 2019
Traumatic Brain Injury - Pipeline by Stemedica Cell Technologies Inc, H1 2019
Traumatic Brain Injury - Pipeline by SynZyme Technologies LLC, H1 2019
Traumatic Brain Injury - Pipeline by Tetra Discovery Partners LLC, H1 2019
Traumatic Brain Injury - Pipeline by Therapeutic Solutions International Inc, H1 2019
Traumatic Brain Injury - Pipeline by Therapix Biosciences Ltd, H1 2019

List of Figures
Number of Products under Development for Traumatic Brain Injury, H1 2019
Number of Products under Development by Companies, H1 2019
Number of Products under Development by Universities/Institutes, H1 2019
Number of Products by Top 10 Targets, H1 2019
Number of Products by Stage and Top 10 Targets, H1 2019
Number of Products by Top 10 Mechanism of Actions, H1 2019
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2019
Number of Products by Top 10 Routes of Administration, H1 2019
Number of Products by Stage and Top 10 Routes of Administration, H1 2019
Number of Products by Top 10 Molecule Types, H1 2019
Number of Products by Stage and Top 10 Molecule Types, H1 2019
  • Depression - Pipeline Review, H1 2019
    Published: 23-May-2019        Price: US 2000 Onwards        Pages: 558
    Depression - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Depression - Pipeline Review, H1 2019, provides an overview of the Depression (Central Nervous System) pipeline landscape. Depression is a mood disorder that causes a persistent feeling of sadness and loss of interest. Signs and symptoms include sleep disturbances, including insomnia or sleeping too much, changes in appetite, anx......
  • Mild Cognitive Impairment - Pipeline Review, H1 2019
    Published: 23-May-2019        Price: US 2000 Onwards        Pages: 131
    Mild Cognitive Impairment - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mild Cognitive Impairment - Pipeline Review, H1 2019, provides an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape. Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is an intermediate stage......
  • Alzheimer's Disease - Pipeline Review, H1 2019
    Published: 29-Apr-2019        Price: US 2500 Onwards        Pages: 1429
    Alzheimer's Disease - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alzheimer's Disease - Pipeline Review, H1 2019, provides an overview of the Alzheimer's Disease (Central Nervous System) pipeline landscape. Alzheimer's disease is a progressive, degenerative condition causing damage to the memory and behavior due to the attack on the neurons. These neurons are responsible for the synthe......
  • Nicotine Addiction - Pipeline Review, H1 2019
    Published: 29-Apr-2019        Price: US 2000 Onwards        Pages: 65
    Nicotine Addiction - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nicotine Addiction - Pipeline Review, H1 2019, provides an overview of the Nicotine Addiction (Central Nervous System) pipeline landscape. Nicotine addiction also called tobacco dependence is an addiction to tobacco products caused by the drug nicotine. Predisposing factors include age, depression, schizophrenia, post-tra......
  • Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019
    Published: 29-Apr-2019        Price: US 2000 Onwards        Pages: 150
    Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019, provides an overview of the Spinal Muscular Atrophy (SMA) (Central Nervous System) pipeline landscape. Spinal muscular atrophy (SMA) is a genetic disease that attacks nerve cells, called motor neurons, in the spinal cord. These critically important cells......
  • Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019
    Published: 29-Apr-2019        Price: US 2000 Onwards        Pages: 154
    Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019, provides an overview of the Attention Deficit Hyperactivity Disorder (ADHD) (Central Nervous System) pipeline landscape. Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include in......
  • Epilepsy - Pipeline Review, H1 2019
    Published: 29-Apr-2019        Price: US 2000 Onwards        Pages: 512
    Epilepsy - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epilepsy - Pipeline Review, H1 2019, provides an overview of the Epilepsy (Central Nervous System) pipeline landscape. Epilepsy is a neurological disorder characterized by the transmission of abnormal signals produced by a group of neurons in the brain which causes seizures. This leads to brief disruptions of the senses and short p......
  • CNS Disorders Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024
    Published: 24-Apr-2019        Price: US 3000 Onwards        Pages: 143
    CNS Disorders Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global CNS Disorders Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the CNS Disorders Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Overall, the report provides an in-depth insight of 2014-2024 global and Chinese CNS Disor......
  • Post-Operative Pain - Pipeline Review, H1 2019
    Published: 23-Apr-2019        Price: US 2000 Onwards        Pages: 265
    Post-Operative Pain - Pipeline Review, H1 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain - Pipeline Review, H1 2019, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape. Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes periphera......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs